Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2440919
Max Phase: Preclinical
Molecular Formula: C37H48F3N9O6
Molecular Weight: 657.82
Molecule Type: Small molecule
Associated Items:
ID: ALA2440919
Max Phase: Preclinical
Molecular Formula: C37H48F3N9O6
Molecular Weight: 657.82
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: N=C(N)NCCC[C@@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(CNC(=O)NCCCCNC(=O)CN)cc1.O=C(O)C(F)(F)F
Standard InChI: InChI=1S/C35H47N9O4.C2HF3O2/c36-22-30(45)39-19-7-8-20-41-35(48)43-24-26-17-15-25(16-18-26)23-42-32(46)29(14-9-21-40-34(37)38)44-33(47)31(27-10-3-1-4-11-27)28-12-5-2-6-13-28;3-2(4,5)1(6)7/h1-6,10-13,15-18,29,31H,7-9,14,19-24,36H2,(H,39,45)(H,42,46)(H,44,47)(H4,37,38,40)(H2,41,43,48);(H,6,7)/t29-;/m1./s1
Standard InChI Key: YHRAPYPKOBSQSC-XXIQNXCHSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 657.82 | Molecular Weight (Monoisotopic): 657.3751 | AlogP: 1.54 | #Rotatable Bonds: 19 |
Polar Surface Area: 216.35 | Molecular Species: BASE | HBA: 6 | HBD: 9 |
#RO5 Violations: 2 | HBA (Lipinski): 13 | HBD (Lipinski): 11 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 12.70 | CX Basic pKa: 11.87 | CX LogP: 0.19 | CX LogD: -2.73 |
Aromatic Rings: 3 | Heavy Atoms: 48 | QED Weighted: 0.05 | Np Likeness Score: -0.48 |
1. Keller M, Kaske M, Holzammer T, Bernhardt G, Buschauer A.. (2013) Dimeric argininamide-type neuropeptide Y receptor antagonists: chiral discrimination between Y1 and Y4 receptors., 21 (21): [PMID:24074877] [10.1016/j.bmc.2013.08.065] |
Source(1):